Targeting Mitogen-Activated Protein Kinase Phosphatase-1 (MKP-1): Structure-Based Design of MKP-1 Inhibitors and Upregulators

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|2|163-173

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.2, 2012-01, pp. : 163-173

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitogen-activated protein kinase phosphatase-1 – a potential therapeutic target in metabolic disease

By Roth Flach Rachel J   Bennett Anton M  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1323-1332

Informa Healthcare

Access to resources Recommend Favorite

Structure-Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 857-868

Bentham Science Publishers

Access to resources Recommend Favorite

Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor- 1 gene in rats

By Tsubokou Y.   Kobayashi N.   Mita S.-i.   Yoshida K.   Matsuoka H.  

European Journal of Pharmacology, Vol. 457, Iss. 2, 2002-12 ,pp. : 85-93

Elsevier

Access to resources Recommend Favorite

Activation of the ERK1/2 Mitogen-Activated Protein Kinase Cascade by Dentin Matrix Protein 1 Promotes Osteoblast Differentiation

By  

Cells Tissues Organs, Vol. 194, Iss. 2-4, 2011-05 ,pp. : 255-260

Karger

Access to resources Recommend Favorite

5-HT 1A receptor-mediated regulation of mitogen-activated protein kinase phosphorylation in rat brain

By Chen J.   Shen C.   Meller E.  

European Journal of Pharmacology, Vol. 452, Iss. 2, 2002-10 ,pp. : 155-162

Elsevier

Access to resources Recommend Favorite